Title : Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers.

Pub. Date : 2010 Dec 1

PMID : 20935474






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Topotecan as a molecular targeting agent which blocks the Akt and VEGF cascade in platinum-resistant ovarian cancers. Topotecan AKT serine/threonine kinase 1 Homo sapiens
2 RESULTS: Topotecan significantly inhibited Cisplatin-induced Akt activation in Caov-3 cells, but not in A2780 cells. Topotecan AKT serine/threonine kinase 1 Homo sapiens
3 Topotecan inhibited not only Cisplatin-induced Akt activation but also VEGF and HIF-1alpha expression. Topotecan AKT serine/threonine kinase 1 Homo sapiens
4 CONCLUSION: We herein demonstrated that Topotecan inhibits Akt kinase activity and VEGF transcriptional activation after Cisplatin treatment in platinum-resistant ovarian cancers. Topotecan AKT serine/threonine kinase 1 Homo sapiens